EpiMetal: an open-source graphical web browser tool for easy statistical analyses in epidemiology and metabolomics

Abstract Motivation An intuitive graphical interface that allows statistical analyses and visualizations of extensive data without any knowledge of dedicated statistical software or programming. Implementation EpiMetal is a single-page web application written in JavaScript, to be used via a modern desktop web browser. General features Standard epidemiological analyses and self-organizing maps for data-driven metabolic profiling are included. Multiple extensive datasets with an arbitrary number of continuous and category variables can be integrated with the software. Any snapshot of the analyses can be saved and shared with others via a www-link. We demonstrate the usage of EpiMetal using pilot data with over 500 quantitative molecular measures for each sample as well as in two large-scale epidemiological cohorts (N >10 000). Availability The software usage exemplar and the pilot data are open access online at [http://EpiMetal.computationalmedicine.fi]. MIT licensed source code is available at the Github repository at [https://github.com/amergin/epimetal].

[1]  Debbie A Lawlor,et al.  Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies , 2017, American journal of epidemiology.

[2]  J. Danesh,et al.  Metabolomic Consequences of Genetic Inhibition of PCSK9 Compared With Statin Treatment , 2018, Circulation.

[3]  Song Gao,et al.  Numero: a statistical framework to define multivariable subgroups in complex population-based datasets. , 2018, International journal of epidemiology.

[4]  Risto Telama,et al.  Cohort profile: the cardiovascular risk in Young Finns Study. , 2008, International journal of epidemiology.

[5]  P. Meikle,et al.  Weight Loss and Exercise Alter the High-Density Lipoprotein Lipidome and Improve High-Density Lipoprotein Functionality in Metabolic Syndrome , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[6]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[7]  J. Mariani,et al.  Sympathetic Neural Adaptation to Hypocaloric Diet With or Without Exercise Training in Obese Metabolic Syndrome Subjects , 2009, Diabetes.

[8]  J. Shaw,et al.  Plasma lipid profiling in a large population-based cohort[S] , 2013, Journal of Lipid Research.

[9]  Ville-Petteri Mäkinen,et al.  Data-driven metabolic subtypes predict future adverse events in individuals with type 1 diabetes , 2017, Diabetologia.

[10]  K. Kaski,et al.  Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes , 2008, Diabetes.

[11]  C. Hoggart,et al.  Genome-wide association analysis of metabolic traits in a birth cohort from a founder population , 2008, Nature Genetics.

[12]  J. Dixon,et al.  A randomized controlled trial of the effects of pioglitazone treatment on sympathetic nervous system activity and cardiovascular function in obese subjects with metabolic syndrome. , 2014, The Journal of clinical endocrinology and metabolism.

[13]  K. Kaski,et al.  Characterization of metabolic interrelationships and in silico phenotyping of lipoprotein particles using self-organizing maps[S] , 2010, Journal of Lipid Research.

[14]  J. Kumpula,et al.  Reconsideration of hydrophobic lipid distributions in lipoprotein particles. , 2008, Chemistry and physics of lipids.

[15]  Alun D. Hughes,et al.  Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase , 2016, Journal of the American College of Cardiology.

[16]  J. Shaw,et al.  High-Throughput Plasma Lipidomics: Detailed Mapping of the Associations with Cardiometabolic Risk Factors. , 2019, Cell chemical biology.

[17]  G. Davey Smith,et al.  Metabolic profiling–multitude of technologies with great research potential, but (when) will translation emerge? , 2016, International journal of epidemiology.

[18]  J. Shaw,et al.  Lipidomic analyses in epidemiology. , 2016, International journal of epidemiology.

[19]  Kimmo Kaski,et al.  Metabolic diversity of progressive kidney disease in 325 patients with type 1 diabetes (the FinnDiane Study). , 2012, Journal of proteome research.

[20]  Pasi Soininen,et al.  Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. , 2015, Circulation. Cardiovascular genetics.

[21]  Mark I. McCarthy,et al.  Early Life Factors and Blood Pressure at Age 31 Years in the 1966 Northern Finland Birth Cohort , 2004, Hypertension.

[22]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[23]  W. Blackwelder,et al.  PLASMA-TRIGLYCERIDES IN REGULATION OF H.D.L.-CHOLESTEROL LEVELS , 1978, The Lancet.